Breaking News Instant updates and real-time market news.

AMRX

Amneal Pharmaceuticals

$6.66

-0.305 (-4.38%)

, TEVA

Teva

$9.48

-0.12 (-1.25%)

06:04
07/08/19
07/08
06:04
07/08/19
06:04

Amneal Pharmaceuticals upgraded to Overweight from Neutral at Piper Jaffray

Piper Jaffray analyst David Amsellem upgraded Amneal Pharmaceuticals (AMRX) to Overweight from Neutral with an unchanged price target of $11. The "massive" selloff among the U.S. major generics companies due largely to opioid-related litigation paints the key players in the space with a broad brush, which is not logical, Amsellem tells investors in a research note. Generics like Teva (TEVA) and Endo (ENDP), that once actively promoted opioid brands, have a greater degree of legal risk relative to companies such as Amneal that have strictly distributed generic opioid products, says the analyst. As a result, he believes shares of Amneal Pharmaceuticals have been "overly punished" and offer an attractive opportunity for value-oriented investors.

AMRX

Amneal Pharmaceuticals

$6.66

-0.305 (-4.38%)

TEVA

Teva

$9.48

-0.12 (-1.25%)

ENDP

Endo

$4.35

-0.23 (-5.02%)

  • 07

    Aug

  • 08

    Aug

  • 09

    Sep

AMRX Amneal Pharmaceuticals
$6.66

-0.305 (-4.38%)

06/12/19
CANT
06/12/19
NO CHANGE
Target $14
CANT
Overweight
Amneal Pharmaceuticals price target lowered to $14 from $35 at Cantor Fitzgerald
Cantor Fitzgerald analyst Louise Chen lowered her price target for Amneal Pharmaceuticals to $14 from $35, driven by multiple contraction, given increasing headwinds from macro factors. The analyst believes that generic consolidation may make it harder for Amneal to compete. Nonetheless, Chen reiterates an Overweight rating on the shares.
06/11/19
LEHM
06/11/19
INITIATION
Target $9
LEHM
Equal Weight
Amneal Pharmaceuticals initiated with an Equal Weight at Barclays
Barclays analyst Balaji Prasad started Amneal Pharmaceuticals with an Equal Weight rating and $9 rice target. The analyst launched coverage of 20 U.S. Specialty Pharmaceuticals with a Neutral industry view. He placed importance on cash flows and companies' ability to manage leverage and improve balance sheets.
05/21/19
05/21/19
UPGRADE

Strong Buy
Amneal Pharmaceuticals upgraded to Strong Buy on valuation Raymond James
As previously reported, Raymond James upgraded Amneal Pharmaceuticals to Strong Buy from Market Perform and established a $13 price target. Analyst Elliot Wilbur believes the selloff in shares more than discounts recent litigation news and said shares are "too cheap" to ignore. The analyst said Amneal is still a strong pipeline play and is a "best-in-show" ANDA "machine" with double digit EBITDA growth over the next two years.
05/21/19
RAJA
05/21/19
UPGRADE
RAJA
Strong Buy
Amneal Pharmaceuticals upgraded to Strong Buy at Raymond James
TEVA Teva
$9.48

-0.12 (-1.25%)

07/05/19
07/05/19
NO CHANGE

Fly Intel: Top five analyst actions
Catch up on today's top five analyst actions with this list compiled by The Fly: 1. Teva (TEVA) upgraded to Buy from Hold at Argus with analyst Jason McCarthy saying the company has been making progress in resolving its "numerous challenges" of the past several years. 2. Senseonics (SENS) downgraded to Market Perform from Outperform at Raymond James with analyst Jayson Bedford stating the company's "persistent headwinds" leave him "less patient" with respect to the shares. 3.Omnova Solutions (OMN) downgraded to Hold from Buy at Deutsche Bank with analyst David Begleiter saying he believes Synthomer paid a "fair but full price" to acquire Omnova and that a competing bidder is unlikely to emerge. 4. Mercer (MERC) downgraded to Neutral from Outperformer at CIBC. 5. BASF (BASFY) initiated with a Neutral at Goldman Sachs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/05/19
07/05/19
UPGRADE
Target $12

Buy
Teva upgraded to Buy from Hold at Argus
As previously reported, Argus analyst Jason McCarthy upgraded Teva to Buy with a price target of $12, saying the company has been making progress in resolving its "numerous challenges" of the past several years. The analyst believes that the company's reliance on Copaxone has declined and its cost base has also decreased "significantly", adding that the generics industry overall is also stabilizing. McCarthy further notes that while Teva could be faced with "several more challenging quarters", he sees its current forward earnings multiple of 3.9-times as an "excessive discount" valuation relative to the peer average of 6.7-times and its historical average of 8.6-times.
07/05/19
ARGS
07/05/19
UPGRADE
ARGS
Buy
Teva upgraded to Buy from Hold at Argus
Argus analyst Jason McCarthy upgraded Teva to Buy from Hold.
06/18/19
BERN
06/18/19
NO CHANGE
Target $11
BERN
Market Perform
Bernstein sees 'no reason to own' Teva, lowers price target to $11
Bernstein analyst analyst Ronny Gal said he sees "no reason to own" Teva shares given the company's weak free cash flow, legal overhangs and valuation. He keeps a Market Perform rating on Teva shares and lowered his price target on the stock to $11 from $17.
ENDP Endo
$4.35

-0.23 (-5.02%)

06/17/19
06/17/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Disney (DIS) downgraded to In-Line from Outperform at Imperial Capital wite analyst David Miller citing valuation. 2. Dow Inc. (DOW) downgraded to Market Perform from Outperform at BMO Capital with analyst John McNulty saying that while the company remains among the "diversified pure-play-commodity companies in the space" with focus on shareholder value and led by "solid" management, its 2019 is looking increasingly challenging due to persisting global trade issues and faltering macro growth. 3. Endo (ENDP) downgraded to Neutral from Buy at Citi with analyst Liav Abraham stating she "cannot ignore the headwinds" associated with the company's opioid-related litigation. 4. LyondellBasell (LYB) downgraded to Hold from Buy at Deutsche Bank with analyst David Begleiter expecting shares to be range-bound through the end of 2019 amid questions into the "depth and duration" of the U.S. ethylene cycle downturn. 5. Ashford Hospitality (AHT) downgraded to Neutral from Buy at DA Davidson with analyst James Lykins noting the company's decision to halve its dividend raises a near-term uncertainty which, along with industry headwinds, warrants a move to the sidelines. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/17/19
SBSH
06/17/19
DOWNGRADE
Target $5
SBSH
Neutral
Citi downgrades Endo to Neutral on opioid litigation headwinds
Citi analyst Liav Abraham downgraded Endo International to Neutral from Buy and lowered her price target for the shares to $5 from $19. While acknowledging the improvement in Endo's underlying business over the past couple of years, the analyst says she "cannot ignore the headwinds" associated with the company's opioid-related litigation. The pathway towards resolution of this issue remains unclear, Abraham tells investors in a research note. Further, the analyst believes "near-term catalysts are unlikely to favor the defendants."
06/17/19
SBSH
06/17/19
DOWNGRADE
Target $5
SBSH
Neutral
Endo downgraded to Neutral from Buy at Citi
Citi analyst Liav Abraham downgraded Endo International to Neutral from Buy and lowered her price target for the shares to $5 from $19.
06/12/19
CANT
06/12/19
NO CHANGE
Target $4.75
CANT
Neutral
Endo price target lowered to $4.75 from $18 at Cantor Fitzgerald
Cantor Fitzgerald analyst Louise Chen lowered her price target for Endo to $4.75 from $18, driven by multiple contraction, given increasing headwinds from macro factors. The analyst reiterates a Neutral rating on the shares.

TODAY'S FREE FLY STORIES

TAP

Molson Coors

$54.37

0.08 (0.15%)

18:06
07/18/19
07/18
18:06
07/18/19
18:06
Hot Stocks
Molson Coors raises quarterly dividend to 57c from 41c per share »

Molson Coors declared a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

MSFT

Microsoft

$136.29

0.06 (0.04%)

18:04
07/18/19
07/18
18:04
07/18/19
18:04
Hot Stocks
Breaking Hot Stocks news story on Microsoft »

Microsoft up over 2%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

BAS

Basic Energy

$1.81

-0.1 (-5.24%)

18:02
07/18/19
07/18
18:02
07/18/19
18:02
Hot Stocks
Basic Energy announces record setting lateral completion in Permian Basin »

Basic Energy Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 13

    Nov

MSFT

Microsoft

$136.29

0.06 (0.04%)

18:02
07/18/19
07/18
18:02
07/18/19
18:02
Hot Stocks
Microsoft CFO continues to expect double digit revenue growth in FY20 »

Sees FY20 operating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

QTRH

Quarterhill

$1.23

(0.00%)

18:02
07/18/19
07/18
18:02
07/18/19
18:02
Hot Stocks
WiLAN unit acquires patent portfolio from Vidiator »

Wi-LAN announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$136.29

0.06 (0.04%)

18:00
07/18/19
07/18
18:00
07/18/19
18:00
Earnings
Microsoft sees total Q1 revenue at implied $31.7B-$32.4B, consensus $32.0B »

By segment: Sees Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

RRGB

Red Robin

$30.58

0.32 (1.06%)

18:00
07/18/19
07/18
18:00
07/18/19
18:00
Hot Stocks
Red Robin up 17% after confirming $40.00 per share offer from Vintage Capital »

In after-hours trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$33.09

-0.17 (-0.51%)

17:54
07/18/19
07/18
17:54
07/18/19
17:54
Periodicals
AT&T mulls sale of Puerto Rican business to pay down debt, Bloomberg says »

AT&T, which is eyeing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 30

    Jul

  • 08

    Aug

RRGB

Red Robin

$30.58

0.32 (1.06%)

17:53
07/18/19
07/18
17:53
07/18/19
17:53
Hot Stocks
Red Robin confirms $40.00 per share cash buyout proposal from Vintage Capital »

Red Robin confirmed it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$136.29

0.06 (0.04%)

17:50
07/18/19
07/18
17:50
07/18/19
17:50
Hot Stocks
Microsoft CFO: Q4 another quarter of double-digit top and bottom line growth »

Says commercial bookings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

HBIO

Harvard Bioscience

$1.78

0.03 (1.71%)

17:46
07/18/19
07/18
17:46
07/18/19
17:46
Hot Stocks
Harvard Bioscience names Michael Rossi CFO »

Harvard Bioscience has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$136.29

0.06 (0.04%)

17:43
07/18/19
07/18
17:43
07/18/19
17:43
Hot Stocks
Microsoft CEO seeing growing momentum across every layer of its stack »

Says LinkedIn saw record…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

ISRG

Intuitive Surgical

$536.44

13.25 (2.53%)

17:38
07/18/19
07/18
17:38
07/18/19
17:38
Hot Stocks
Intuitive Surgical falls after Q2 report, despite earnings beat »

Shares of Intuitive are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 26

    Aug

  • 09

    Sep

GLD

SPDR Gold Shares

$136.44

1.85 (1.37%)

17:33
07/18/19
07/18
17:33
07/18/19
17:33
Hot Stocks
SPDR Gold Shares holdings rise to 814.62MT from 803.18MT »

This is the highest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAL

Western Alliance

$44.45

0.74 (1.69%)

17:29
07/18/19
07/18
17:29
07/18/19
17:29
Earnings
Western Alliance reports Q2 EPS 1.19, consensus $1.16 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 06

    Aug

ENB

Enbridge

$36.29

0.17 (0.47%)

17:22
07/18/19
07/18
17:22
07/18/19
17:22
Initiation
Enbridge initiated at Goldman Sachs »

Enbridge initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

SEAS

SeaWorld

$33.81

0.38 (1.14%)

17:21
07/18/19
07/18
17:21
07/18/19
17:21
Periodicals
Travel company Virgin Holidays will end selling tickets to SeaWorld, Sun says »

According to the Sun, …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

IEP

Icahn Enterprises

$75.06

-0.14 (-0.19%)

17:20
07/18/19
07/18
17:20
07/18/19
17:20
Syndicate
Breaking Syndicate news story on Icahn Enterprises »

Icahn Enterprises files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RICK

RCI Hospitality

$16.80

0.08 (0.48%)

17:13
07/18/19
07/18
17:13
07/18/19
17:13
Hot Stocks
RCI Hospitality auditor BDO resigns, company files Nasdaq compliance plan »

RCI Hospitality announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BEDU

Bright Scholar

$9.60

-0.06 (-0.62%)

17:03
07/18/19
07/18
17:03
07/18/19
17:03
Earnings
Bright Scholar reports Q3 EPS 16c, two estimates 21c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

ISRG

Intuitive Surgical

$536.44

13.25 (2.53%)

17:03
07/18/19
07/18
17:03
07/18/19
17:03
Hot Stocks
Intuitive Surgical refines FY19 procedure growth view to 16%-17% from 15%-17% »

Still sees FY19 tax rate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 26

    Aug

  • 09

    Sep

CUB

Cubic

$66.59

-0.37 (-0.55%)

17:01
07/18/19
07/18
17:01
07/18/19
17:01
Hot Stocks
Cubic receives extension on simulation services contract in Australia »

Cubic Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLRO

ClearOne

$2.27

(0.00%)

16:52
07/18/19
07/18
16:52
07/18/19
16:52
Hot Stocks
Shure files patent infringement suit against ClearOne »

Shure announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ISRG

Intuitive Surgical

$536.44

13.25 (2.53%)

16:50
07/18/19
07/18
16:50
07/18/19
16:50
Hot Stocks
Intuitive Surgical says 74% of systems placed in Q2 were da Vinci XIs »

Says team has done a nice…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 26

    Aug

  • 09

    Sep

ETN

Eaton

$79.03

-0.36 (-0.45%)

16:49
07/18/19
07/18
16:49
07/18/19
16:49
Hot Stocks
Eaton acquires Innovative Switchgear Solutions »

Eaton announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.